DDIS-29. BRAIN-PENETRANT MICROTUBULE-TARGETING AGENT, ST-401, KILLS GLIOBLASTOMA THROUGH A NOVEL MECHANISM

Glioblastomas are particularly sensitive to mitotic disruption when compared with nonmalignant cells and thus microtubule-targeting agents (MTA) represent promising therapeutics to treat patients with glioblastomas; but few such compounds pass the blood brain barrier. We developed a series of modifi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Horne, Eric, Xu, Cong, Vicente, Juan-Jesus, Cimino, P J, Wagenbach, Michael, Hamel, Ernest, Gussio, Rick, Diaz, Philippe, Uhlenbruck, Benjamin, Deckwerth, Thomas, Wordeman, Linda, Holland, Eric, Stella, Nephi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Drug Discovery
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847318/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.280
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak